For neurodegenerative disease clinical trials, understanding how a condition is progressing and whether a treatment is having an effect can be difficult using traditional assessments alone. Biomarker science, digital health technologies and precision medicine are creating new ways to capture objective measures of disease. As the prevalence of neurodegenerative conditions continues to grow, there is an increasing need for innovative tools to detect disease, strengthen clinical trial design and support the development of new therapies. This webinar explores how emerging biomarker strategies can help address these challenges across clinical research and therapeutic development.
Biological and imaging biomarkers, together with digital and wearable technologies, are enabling researchers to detect disease earlier, characterize patient populations more accurately, track disease progression and assess treatment response with greater precision. These objective, actionable measures can help inform decision-making across the drug development process.
The featured panelists will examine how biological, digital and wearable markers are being applied across neurodegenerative disease research. Attendees will learn how these approaches can support more efficient clinical trials, strengthen patient selection, enable more personalized treatment strategies and contribute to the development of next-generation therapies.
The session will also examine real-world applications, practical implementation considerations and emerging trends influencing the future of CNS research. Attendees will gain insight into both the opportunities and challenges of incorporating innovative biomarker strategies into research programs and clinical development initiatives. As neurodegenerative disease research becomes increasingly precise, data-driven and patient-centered, biomarkers and digital technologies will play an important role in advancing new treatments and improving patient outcomes.
Register for this webinar to learn how biomarker strategies can advance neurodegenerative disease research and support more precise, data-driven clinical trials.
Who Should Attend
This webinar will appeal to:
Clinical Development leaders
Clinical Research Scientists
Neuroscience/CNS Researchers
Biomarker Scientists
Translational Medicine Scientists
Digital Health leaders
What You Will Learn
Attendees will gain insight into:
How biological, digital, imaging and wearable biomarkers can support earlier detection and more precise assessment of neurodegenerative diseases
How biomarker data can strengthen patient selection, clinical trial design and development of more personalized therapies
How digital health technologies and wearable devices can monitor disease progression and treatment response
Key considerations and evolving trends influencing biomarker-driven CNS drug development and precision medicine
Register free on Xtalks:
https://xtalks.com/webinars/from-detection-to-decisions-biomarkers-in-neurodegenerative-disease/
